These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
444 related articles for article (PubMed ID: 18377613)
1. Hypopigmented post-kala-azar dermal leishmaniasis. Ramesh V; Ramam M; Singh R; Salotra P Int J Dermatol; 2008 Apr; 47(4):414-6. PubMed ID: 18377613 [No Abstract] [Full Text] [Related]
2. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis, or a rare presentation of visceral leishmaniasis with extensive skin manifestations. Ramesh V Int J Dermatol; 2007 Dec; 46(12):1326. PubMed ID: 18173544 [No Abstract] [Full Text] [Related]
4. Post-kala-azar dermal leishmaniasis mimicking leprosy: experience with 4 patients, with some unusual features in 1. Dhar S; Kaur I; Dawn G; Sehgal S; Kumar B Lepr Rev; 1995 Sep; 66(3):250-6. PubMed ID: 7500822 [TBL] [Abstract][Full Text] [Related]
5. Nerve involvement in Indian post kala-azar dermal leishmaniasis. Khandpur S; Ramam M; Sharma VK; Salotra P; Singh MK; Malhotra A Acta Derm Venereol; 2004; 84(3):245-6. PubMed ID: 15202852 [No Abstract] [Full Text] [Related]
6. Hypersensitivity reaction over lesions of post-kala-azar dermal leishmaniasis mimicking type 1 reaction in leprosy. Dhar S; Malakar S Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):66-7. PubMed ID: 10407631 [No Abstract] [Full Text] [Related]
7. Comment: distinguishing post-kala-azar dermal leishmaniasis from leprosy: experience in the Sudan. Babu VV Lepr Rev; 1994 Jun; 65(2):150. PubMed ID: 7968192 [No Abstract] [Full Text] [Related]
8. Reactivity of various leishmanial antigens in a direct agglutination test and their value in differentiating post-kala azar dermal leishmaniasis from leprosy and other skin conditions. El Harith A; Chowdhury S; Al-Masum A; Semião-Santos S; Das PK; Akhter S; Vetter JC; Haq I J Med Microbiol; 1996 Feb; 44(2):141-6. PubMed ID: 8642576 [TBL] [Abstract][Full Text] [Related]
9. A clinical and histopathological study of macular type of post-kala-azar dermal leishmaniasis. Ramesh V; Singh N Trop Doct; 1999 Oct; 29(4):205-7. PubMed ID: 10578632 [TBL] [Abstract][Full Text] [Related]
10. Post-kala-azar dermal leishmaniasis and visceral leishmaniasis in a child--or is it para-kala-azar dermal leishmaniasis? Mendiratta V; Chander R Int J Dermatol; 2009 Sep; 48(9):1027-8. PubMed ID: 19703001 [No Abstract] [Full Text] [Related]
14. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal. Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997 [TBL] [Abstract][Full Text] [Related]
15. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans. Sreenivas G; Raju BV; Singh R; Selvapandiyan A; Duncan R; Sarkar D; Nakhasi HL; Salotra P J Clin Microbiol; 2004 Apr; 42(4):1739-41. PubMed ID: 15071036 [TBL] [Abstract][Full Text] [Related]
16. Post kala azar dermal leishmaniasis in Sudan. Kordofani YM; Nour YT; El-Hassan AM; Shalayel MH East Mediterr Health J; 2001 Nov; 7(6):1061-4. PubMed ID: 15332749 [TBL] [Abstract][Full Text] [Related]
17. Atypical disseminated leishmaniasis similar to post-kala-azar dermal leishmaniasis in a Brazilian AIDS patient infected with Leishmania (Leishmania) infantum chagasi: a case report. Carnaúba D; Konishi CT; Petri V; Martinez IC; Shimizu L; Pereira-Chioccola VL Int J Infect Dis; 2009 Nov; 13(6):e504-7. PubMed ID: 19447660 [TBL] [Abstract][Full Text] [Related]
18. Post kala-azar dermal leishmaniasis: the Kenyan experience. Muigai R; Gachihi GS; Oster CN; Were JB; Nyakundi PM; Chunge CN; Kirigi G; Rashid JR East Afr Med J; 1991 Oct; 68(10):801-6. PubMed ID: 1667521 [TBL] [Abstract][Full Text] [Related]
19. Atypical presentation of post-kala-azar dermal leishmaniasis. Islam QT; Basher A Lancet Infect Dis; 2017 Nov; 17(11):1218. PubMed ID: 29115271 [No Abstract] [Full Text] [Related]
20. Immune response following miltefosine therapy in a patient with post-kala-azar dermal leishmaniasis. Ansari NA; Ramesh V; Salotra P Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1160-2. PubMed ID: 18639311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]